IKT - Inhibikase Therapeutics, Inc.
2.07
0.210 10.145%
Share volume: 106,031
Last Updated: 04-11-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.01%
PREVIOUS CLOSE
CHG
CHG%
$1.86
0.21
0.11%
Summary score
35%
Profitability
25%
Dept financing
12%
Liquidity
75%
Performance
40%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 30-Sep-2020 - 30-Sep-2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-24.16%
Return on assets
-30.39%
Return on sales
-36732160.16%
Return on invested capital
147.24%
Total debt ratio
24.98%
Debt ratio change over timeo
-0.8%
Current Ratio
7.83%
Quick Ratio
9.2%
Cash Position Ratio
7.19%
Short-term ratios 30-Sep-2023 - 30-Sep-2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-53.34%
Return on assets
-61.43%
Return on sales
-440356600%
Return on invested capital
124.98%
Total debt ratio
51.25%
Debt ratio change over timeo
-0.5%
Current Ratio
2.48%
Quick Ratio
3.34%
Cash Position Ratio
1.55%
Last quarter ratios 30-Sep-2024
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-133.14%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
112.12%
Debt ratio change over time
-0.04%
Current Ratio
0.85%
Quick Ratio
0%
Cash Position Ratio
0.19%
Performance ratios (change over 4 years) 30-Sep-2020 - 30-Sep-2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-120.35%
Return on assets
-123.34%
Return on sales
-31384762.59%
Return on invested capital
5.4%
Total debt ratio
-80.25%
Debt ratio change over time
-0.8%
Current Ratio
4.78%
Quick Ratio
5.47%
Cash Position Ratio
4.36%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | IKT | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | -24.16% | 18.34% | 4.52% | 3.79% |
| Return on assets | -30.39% | 3.17% | 3.15% | 2.2% |
| Return on sales | -36732160.16% | 30.73% | 29.2% | 22.98% |
| Return on invested capital | 147.24% | 5.33% | 2.28% | 3.84% |
| Profitability | 25% | 76% | 55% | 42% |
| Total debt ratio | 24.98% | 91.7% | 67.74% | 47.72% |
| Debt ratio change over time | -0.8% | 17.73% | 109.18% | 3.58% |
| Dept financing | 7% | 29% | 43% | 14% |
| Current Ratio | 2.48% | 1.41% | 1.2% | 2% |
| Quick Ratio | 3.34% | 0.99% | 1.04% | 1.27% |
| Cash Position Ratio | 1.55% | 0.49% | 0.43% | 0.4% |
| Liquididy | 75% | 13% | 9% | 15% |
| Short-term ratios | IKT | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | -53.34% | 0% | -8.76% | 2.65% |
| Return on assets | -61.43% | 2.14% | 1.23% | 2.1% |
| Return on sales | -440356600% | 18.91% | 9.38% | 23.56% |
| Return on invested capital | 124.98% | 0% | -5.08% | 2.47% |
| Profitability | 25% | 45% | 24% | 75% |
| Total debt ratio | 51.25% | 93.35% | 66.59% | 42.7% |
| Debt ratio change over time | -0.5% | 0% | 5.11% | 1.77% |
| Dept financing | 14% | 25% | 43% | 20% |
| Current Ratio | 2.48% | 1.41% | 1.2% | 2% |
| Quick Ratio | 3.34% | 0.99% | 1.04% | 1.27% |
| Cash Position Ratio | 1.55% | 0.49% | 0.43% | 0.4% |
| Liquididy | 75% | 30% | 27% | 36% |
